David W. Kaufman, ScD
Director
Boston University Medical Campus
Slone Epidemiology Center

ScD, Harvard University
MS, Harvard University
BA, Bethel College



David W. Kaufman is Professor of Epidemiology at the Boston University School of Public Health and Director of the Slone Epidemiology Center. He obtained his M.S. and Sc.D. in Epidemiology from Harvard School of Public Health. In 1975 he joined the newly created Drug Epidemiology Unit (now the Slone Epidemiology Center ) as a Research Associate. His early career as an epidemiologist at the DEU was primarily spent in studies of drugs and other factors in relation to cancer, heart disease, and various other conditions. Together with Drs. Slone, Shapiro, and Lynn Rosenberg, he participated in the development of Case-Control Surveillance. In the 1980s, Dr. Kaufman was co-investigator of the International Agranulocytosis and Aplastic Anemia Study, a pioneering effort in the evaluation of these extremely rare but often drug-induced blood dyscrasias that was conducted in seven countries with several hundred cases enrolled. He has directed studies of aplastic anemia in Thailand and the United States. The Thai study is the largest epidemiological investigation of aplastic anemia that has been conducted, with over 500 cases and 2200 controls. Dr. Kaufman pursued his interest in rare drug induced diseases as principal investigator of an international study of Stevens-Johnson syndrome and toxic epidermal necrolysis conducted in four countries in Europe, and a study of anaphylaxis conducted in Spain, Hungary, India, and Sweden. Other major activities have included an international study of analgesics in relation to upper gastrointestinal bleeding and the National Analgesic Nephropathy Study, a multicenter study of end stage renal disease patients in three regions of the U.S. Dr. Kaufman worked closely with Allen Mitchell in the implementation of the Slone Survey, a U.S. population-based survey of medication use. He was principal investigator of a recently completed study that documented an inverse relationship between Oxalobacter formigenes, an oxalate metabolizing bacterium found in the colons of about 40% of the normal population, and calcium oxalate kidney stones. He also directed the Patient Registries at Slone: Myeloma and MDS, a recent nationwide effort that followed patients with the two diseases through the course of their illness. Currently Dr. Kaufman is co-principal investigator for a large scale behavioral surveillance program of acetaminophen users and is involved in other postmarketing surveillance activities. He was Assistant Director of the Slone Epidemiology Unit from 1986 to 1997, and was Associate Director from 1998 to 2016.

Professor
Boston University School of Public Health
Epidemiology




Behavioral Surveillance of Acetaminophen Users and Non-Users
03/16/2010 - 12/31/2018 (PI)
McNeill Consumer Healthcare


Evaluation of the Feasibility of a Study of Potential Clinical Sequelae from Brain Hyperintensity Due to Gadolinium-Based Contrast Agents
12/13/2017 - 12/12/2018 (PI)
GE Healthcare, Inc.


Protocol for Development for a Feasibility Study of Thromboembolic Events & Mortality among Users of Beriplex
08/01/2012 - 07/31/2015 (PI)
CSL Behring LLC


Privigen use and haemolytic anaemia in adults and children and the Privigen safety profile in children with CIDP - an observational hospital-based cohort study in the US (Study IGPRO10_5003)
10/22/2014 - 12/31/2014 (PI)
CSL Behring LLC


Sanofi: Pilot study to explore using a physician-based social networking site for enrollment of patients with myeloproliferate neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Sanofi-Aventis, U.S., LLC


Onyx: Pilot Study to explore using a physician-based social networking site for enrollment of patients with myeloproliferative neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Onyx Pharmaceuticals, Inc.


Incyte: Pilot study to explore using a physician-based social networking site for enrollment of patients with myeloproliferative neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Incyte Corporation


Oxalobacter Formigenes and Other Factors In Urolithiasis
08/01/2003 - 07/31/2007 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK62270 03

Herbal Medicine Use in Minority Populations in the U.S.
04/01/2004 - 03/31/2007 (PI)
NIH/Center for Complementary & Alternative Medicine
5 R21 AT02239 02

Cardiovascular Disease Risks of Meloxicam and other NSAIDS
04/06/2005 - 03/31/2006 (PI)
Boehringer Ingelheim Pharmaceuticals, Inc. (Germany)

Showing 10 of 17 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2005 Herbal Medicine Use in Minority Populations in the US 5R21AT002239-02 1
2005 Oxalobacter Formigenes and Other Factors in Urolithiasis 5R01DK062270-03 4
2004 Herbal Medicine Use in Minority Populations in the US 1R21AT002239-01 1
2004 Oxalobacter Formigenes and Other Factors in Urolithiasis 5R01DK062270-02 4
2003 Oxalobacter Formigenes and Other Factors in Urolithiasis 1R01DK062270-01A1 4
2000 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 5R01HL035068-09 14
1999 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 5R01HL035068-08 14
1998 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 2R01HL035068-07A1 14
1995 DATA FROM TWO STUDIES OF BLOOD DYSCRASIAS 5R03HL052351-02
1995 ANALGESIC AND NSAID USE AND GASTROINTESTINAL BLEEDING 5R01DK036997-08 6
Showing 10 of 24 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Weinstock LB, Afrin LB, Reiersen AM, Brook J, Blitshteyn S, Ehrlich G, Schofield JR, Kinsella L, Kaufman D, Dempsey T, Molderings GJ. Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome. Brain Behav Immun Health. 2025 Oct; 48:101048. PMID: 40686928; PMCID: PMC12270938; DOI: 10.1016/j.bbih.2025.101048;
     
  2. Buckley MS, Smith SE, Birriel B, Radosevich JJ, Dzierba AL, Roberts RJ, Barletta JF, Gershengorn HB, Sikora A, Peterson LK, Bodkin R, Kaufman D, Ardiles T, Uppalapu S, Tompeck AJ, Dabrowski P, Close L, Brewer H, Jontz A, Downs B, Cox LA, Alexander SA, Harrison K, MacLaren R. ICU Patient-to-Pharmacist Ratios: A Prospective, Multicenter Time-Motion Study. Crit Care Med. 2025 Apr 01; 53(4):e863-e873. PMID: 40009037
     
  3. Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou T. Innovation in Breast Surgery: Practical and Ethical Considerations. Ann Surg Oncol. 2022 Oct; 29(10):6144-6150. PMID: 35854028
     
  4. Wiestner A, Issaragrisil S, Kaufman DW, Ozawa K, Nakao S, Kajigaya S, Wang J, Wu Z, Binh VTT, Dhawan R, Nair V. Collaborations, colleagues, and friendships: The Hematology Branch and blood disease centers in Asia. Semin Hematol. 2022 Jan; 59(1):6-12. PMID: 35491061
     
  5. Sulaiman I, Chung M, Angel L, Tsay JJ, Wu BG, Yeung ST, Krolikowski K, Li Y, Duerr R, Schluger R, Thannickal SA, Koide A, Rafeq S, Barnett C, Postelnicu R, Wang C, Banakis S, Pérez-Pérez L, Shen G, Jour G, Meyn P, Carpenito J, Liu X, Ji K, Collazo D, Labarbiera A, Amoroso N, Brosnahan S, Mukherjee V, Kaufman D, Bakker J, Lubinsky A, Pradhan D, Sterman DH, Weiden M, Heguy A, Evans L, Uyeki TM, Clemente JC, de Wit E, Schmidt AM, Shopsin B, Desvignes L, Wang C, Li H, Zhang B, Forst CV, Koide S, Stapleford KA, Khanna KM, Ghedin E, Segal LN. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat Microbiol. 2021 Oct; 6(10):1245-1258. PMID: 34465900
     
  6. Ascierto PA, Fox BA, Urba WJ, Anderson AC, Atkins MB, Borden EC, Brahmer JR, Butterfield LH, Cesano A, Chen DC, de Gruijl TD, Dillman RO, Drake CG, Emens LA, Gajewski TF, Gulley JL, Stephen Hodi FJ, Hwu P, Kaufman D, Kaufman HL, Lotze MT, McNeel DG, Margolin KM, Marincola FM, Mastrangelo MJ, Maus MV, Parkinson DR, Romero PJ, Sondel PM, Spranger S, Sznol M, Weiner GJ, Wigginton JM, Weber JS. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. J Immunother Cancer. 2020 Apr; 8(1).View Related Profiles. PMID: 32300051
     
  7. Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S. Five-year trends in acetaminophen use exceeding the recommended daily maximum dose. Br J Clin Pharmacol. 2019 05; 85(5):1028-1034. PMID: 30740763; PMCID: PMC6475729; DOI: 10.1111/bcp.13894;
     
  8. Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, Sher X, Liu XQ, Lu H, Nebozhyn M, Zhang C, Lunceford JK, Joe A, Cheng J, Webber AL, Ibrahim N, Plimack ER, Ott PA, Seiwert TY, Ribas A, McClanahan TK, Tomassini JE, Loboda A, Kaufman D. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science. 2018 Oct 12; 362(6411). PMID: 30309915
     
  9. Kelly JP, Battista DR, Shiffman S, Malone MK, Weinstein RB, Kaufman DW. Knowledge of dosing directions among current users of acetaminophen-containing medications. J Am Pharm Assoc (2003). 2018 Sep - Oct; 58(5):492-498. PMID: 30041852
     
  10. Shiffman S, Battista DR, Kelly JP, Malone MK, Weinstein RB, Kaufman DW. Exceeding the maximum daily dose of acetaminophen with use of different single-ingredient OTC formulations. J Am Pharm Assoc (2003). 2018 Sep - Oct; 58(5):499-504. PMID: 30030041
     
Showing 10 of 173 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 164 publications over 43 distinct years, with a maximum of 11 publications in 1980

YearPublications
198011
19813
19825
19836
19845
19858
19865
19876
19885
19897
19903
19915
19923
19934
19941
19954
19964
19978
19982
19995
20002
20013
20023
20032
20054
20065
20072
20088
20095
20102
20115
20122
20132
20142
20152
20162
20171
20185
20191
20201
20211
20222
20252
Contact for Mentoring:

72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Kaufman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_